Production (Stage)
Legend Biotech Corporation
LEGN
$35.00
$3.5211.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.65% | 16.49% | |||
| Total Other Revenue | -59.82% | -20.28% | |||
| Total Revenue | 4.57% | 16.43% | |||
| Cost of Revenue | -2.85% | 18.12% | |||
| Gross Profit | 166.71% | -11.35% | |||
| SG&A Expenses | -12.86% | 4.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.03% | 13.41% | |||
| Operating Income | 32.43% | -6.54% | |||
| Income Before Tax | -344.70% | 133.51% | |||
| Income Tax Expenses | -87.45% | 220.79% | |||
| Earnings from Continuing Operations | -483.94% | 120.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -483.94% | 120.97% | |||
| EBIT | 32.43% | -6.54% | |||
| EBITDA | 33.06% | -6.00% | |||
| EPS Basic | -482.98% | 120.97% | |||
| Normalized Basic EPS | -317.95% | 137.17% | |||
| EPS Diluted | -482.98% | 120.97% | |||
| Normalized Diluted EPS | -339.53% | 133.82% | |||
| Average Basic Shares Outstanding | 0.24% | 0.02% | |||
| Average Diluted Shares Outstanding | -8.76% | 9.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||